Celldex Therapeutics (CLDX) Posts Q3 Loss of 29c/Share

November 8, 2013 8:05 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q3 EPS of ($0.29), $0.05 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found